Clinical Trials in New York State

Showing 4801-4820 of 13,041 trials

A Post Market Study to Confirm the Safety and Performance of the Signia™ Stapling System.

NCT03515811

The objectives of this prospective, two-arm, multicenter post-market study is to confirm safety and performance through the incidence of subjects reporting serious adverse device effects (ADEs) up to and including 30 days following use of Signia™ Stapling System with Endo GIA™ with Tri-Staple™ Technology and Tri-Staple™ 2.0 Intelligent Reloads in subjects undergoing indicated abdominal or thoracic procedures for resection, transection and creation of anastomosis per the IFU.

Abdominal InjuryThoracic Diseases

Medtronic - MITG136 participantsStarted Jan 2019

Los Angeles, California, United States • Albany, New York, United States • Cary, North Carolina, United States +8 more locations

COMPLETEDPhase 369 miles

Myocardial Ischemia and Transfusion

NCT02981407

The purpose of this study is to compare two red blood cell transfusion strategies (liberal and restrictive) for patients who have had an acute myocardial infarction and are anemic.

Myocardial InfarctionAnemia

Rutgers, The State University of New Jersey3,506 participantsStarted Apr 2017

Little Rock, Arkansas, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +130 more locations

A Post Market Study to Confirm the Safety and Performance of the Signia™ Stapling System.

Myocardial Ischemia and Transfusion

Find Trials by Condition in New York State

Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)

Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)

Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Adult Participants Undergoing Open-chest Cardiac Surgery (NOVA)

VIA Disc NP Registry

RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65

Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

An Efficacy and Safety Study of 24 Week Treatment With Mavodelpar (REN001) in Primary Mitochondrial Myopathy Patients

A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus

Gan & Lee Insulin Glargine Target Type (1) Evaluating Research

Multisystemic Therapy-Emerging Adults (MST-EA) for Substance Abuse

A Study of TAK-071 in People With Parkinson Disease

Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates

ALXN1210 (Ravulizumab) Versus Eculizumab in Complement Inhibitor Treatment-Naïve Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Vascular Access Outcome Measure for Function: a vaLidation Study In haemoDialysis

Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2